Your session is about to expire
← Back to Search
Scleral Lens for Ocular Hypertension
N/A
Recruiting
Led By Cherie Nau, OD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Not on topical medication for glaucoma
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, every half hour for 4 hours
Awards & highlights
Study Summary
This trial will test if a scleral contact lens raises intraocular pressure in ocular hypertensive patients.
Who is the study for?
This trial is for adults with ocular hypertension, which means they have high eye pressure. They can join if they've had cataract surgery but not other eye surgeries or treatments for glaucoma. Participants should have a history of wearing contact lenses, just not scleral lenses, and must skip their usual lenses on the study day.Check my eligibility
What is being tested?
The study is testing whether wearing a special type of rigid contact lens called a scleral lens affects the pressure inside the eyes of people who already have higher than normal intraocular pressure.See study design
What are the potential side effects?
While specific side effects are not listed, wearing scleral lenses may cause discomfort, redness in the eyes, or potentially increase eye pressure which this study aims to investigate.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am not using any eye drops for glaucoma.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, every half hour for 4 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, every half hour for 4 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intraocular Pressure (IOP)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Study EyeExperimental Treatment1 Intervention
One eye will be randomly selected to wear the scleral lenses to be worn during study measurements
Group II: Control EyeActive Control1 Intervention
Non-lens wearing eye
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Scleral Lens
2018
N/A
~30
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,213 Previous Clinical Trials
3,766,990 Total Patients Enrolled
1 Trials studying Ocular Hypertension
100 Patients Enrolled for Ocular Hypertension
Cherie Nau, ODPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not using any eye drops for glaucoma.I have had cataract surgery with lens implant.I have been diagnosed with high eye pressure over the last 3 years.I am using eye drops for glaucoma.I have had eye surgery that was not just for cataracts.I have an eye condition.I am 18 years old or older.I wear contact lenses but can avoid wearing them on the day of the study.
Research Study Groups:
This trial has the following groups:- Group 1: Study Eye
- Group 2: Control Eye
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any slots available for participation in this trial?
"As detailed on clinicaltrials.gov, this medical research project is currently in the process of enrolment. The trial was made publically available on July 1st 2020 and its most recent update happened April 1st 2022."
Answered by AI
What is the total cohort size for this medical experiment?
"That is correct. Accoring to clinicaltrials.gov, this medical trial was created on July 1st 2020 and last amended on April 1st 2022. Currently, 21 participants are needed from one location for the study's purposes."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger